The emerging approach of the medication represents a major development in the management of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide258607.blogs-service.com/73153328/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment